Association of survivin splice variants with prognosis and treatment of breast cancer

doi:10.5306/wjco.v5.i5.883

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 5

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8557)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

506

WORD

447

HTML

5086

Figures (1-2)

201

Tables (1-3)

160

Sum=6400

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1016

Download

1141

Sum=2157

Dec 10, 2014 (publication date) through Oct 3, 2024

Times Cited of This Article

Times Cited (26)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Clin Oncol. Dec 10, 2014; 5(5): 883-894
Published online Dec 10, 2014. doi: 10.5306/wjco.v5.i5.883

Table 2 Panel of 21 genes used in oncotype DX breast cancer assay

Proliferation group	Invasion group	Estrogen group	HER2 group		Reference genes
Ki-67¹	ST3	ER	GRB7 (growth factor receptor-bound protein 7)	GSTM1¹	ACTB¹
STK15¹	CTSL2	PR¹	HER2 [human EGF (epidermal growth factor) receptor 2]	CD68	GAPDH¹
BIRC5 (Survivin)¹		Bcl2			RPLPO¹
CCNB1¹		SCUBE2 [Signal peptide CUB (complement proteins C1r/C1s, Uegf, and Bmp 1)-EGF domain-containing protein 2]		BAG1	GUS¹
MYBL2¹					TFRC¹

¹Genes used in 12-gene oncotype DX for ductal carcinoma in situ. ER: Estrogen receptor; PR: Progesterone receptor; Bcl2: B-cell CLL/lymphoma 2; ST3: Stromelysin 3; CTSL2: Cathepsin L2; Ki-67: Kinase inhibitor; STK15: Serine/threonine kinase 15; CCNB1: Cyclin B1; MYBL2: Myeloblastosis family transcription factor-like 2; ACTB: Beta-actin; GAPDH: Glyceraldehyde-3-phosphate dehydrogenase; RPLPO: Ribosomal phosphoprotein; GUS: β-glucuronidase; TFRC: Transferrin receptor; GSTM1: Glutathione S-transferase M1 gene; CD68: CD68 molecule; BAG1: Bcl2–associated athanogene 1.

Citation: Pavlidou A, Kroupis C, Dimas K. Association of survivin splice variants with prognosis and treatment of breast cancer. World J Clin Oncol 2014; 5(5): 883-894
URL: https://www.wjgnet.com/2218-4333/full/v5/i5/883.htm
DOI: https://dx.doi.org/10.5306/wjco.v5.i5.883